{"log_id": 192656600985543238, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.008922, "average": 0.951556, "min": 0.482235}, "location": {"width": 1258, "top": 191, "height": 50, "left": 219}, "words": "少、血钠过少(血钠<130meg/L),已有低血压(收缩压<90mmHg)的病人,以及患不稳定性心功能"}, {"probability": {"variance": 3.1e-05, "average": 0.997945, "min": 0.975235}, "location": {"width": 543, "top": 242, "height": 45, "left": 221}, "words": "不全和接受高剂量血管扩张剂治疗的病人"}, {"probability": {"variance": 0.000874, "average": 0.986558, "min": 0.875405}, "location": {"width": 628, "top": 285, "height": 47, "left": 191}, "words": "5.老年人及肝或肾功能减退的病人不需降低剂量"}, {"probability": {"variance": 0.000169, "average": 0.989615, "min": 0.968317}, "location": {"width": 157, "top": 363, "height": 36, "left": 86}, "words": "【不良反应】"}, {"probability": {"variance": 0.006392, "average": 0.972173, "min": 0.511275}, "location": {"width": 1281, "top": 415, "height": 50, "left": 194}, "words": "本品最常见的副作用是头晕、咳嗽、上呼吸道症状、恶心或呕吐、腹泻和腹痛、心悸或胸痛、皮疹"}, {"probability": {"variance": 0.03195, "average": 0.918342, "min": 0.372148}, "location": {"width": 660, "top": 463, "height": 45, "left": 194}, "words": "或瘙痒、骨骼肌疼或感觉异常、疲劳和味觉障碍"}, {"probability": {"variance": 0.007197, "average": 0.969386, "min": 0.56223}, "location": {"width": 1283, "top": 502, "height": 50, "left": 194}, "words": "在治疗心力衰竭的试验中,与其它ACE抑制剂相同,可引起低血压,包括直立性低血压,偶有报道"}, {"probability": {"variance": 0.008197, "average": 0.977059, "min": 0.484978}, "location": {"width": 895, "top": 548, "height": 47, "left": 196}, "words": "用ACE担制剂治疗的病人发生胰腺炎,在某些病例已被证明是致命的"}, {"probability": {"variance": 0.002584, "average": 0.987474, "min": 0.739433}, "location": {"width": 744, "top": 591, "height": 47, "left": 194}, "words": "副作用的发生率和类型在年轻病人和老年病人之间无区别"}, {"probability": {"variance": 0.004222, "average": 0.977934, "min": 0.648485}, "location": {"width": 1078, "top": 634, "height": 50, "left": 194}, "words": "实验室检查显示有轻废暂时性的血红蛋白和红细胞值减少,偶见血尿素氮轻度升高"}, {"probability": {"variance": 0.008692, "average": 0.96235, "min": 0.536478}, "location": {"width": 1064, "top": 701, "height": 50, "left": 84}, "words": "【禁忌】对本品或其它血管紧张素转换酶抑制剂过敏者、妊娠期及哺乳期妇女禁用"}, {"probability": {"variance": 6e-06, "average": 0.997272, "min": 0.993602}, "location": {"width": 155, "top": 799, "height": 34, "left": 89}, "words": "【注意事项"}, {"probability": {"variance": 0.004422, "average": 0.975673, "min": 0.68943}, "location": {"width": 1283, "top": 851, "height": 47, "left": 194}, "words": "1.低血压:与所有的ACE抑制剂相同,可能观察到低血压反应。如果发生低血压,一般在首次剂量"}, {"probability": {"variance": 0.011951, "average": 0.968831, "min": 0.453949}, "location": {"width": 1253, "top": 897, "height": 45, "left": 221}, "words": "时发生,对大多数病例,病人躺下后症状即可减轻,一旦病人血压稳定,暂时的低血压偶发事件"}, {"probability": {"variance": 0.004748, "average": 0.976774, "min": 0.759035}, "location": {"width": 328, "top": 950, "height": 36, "left": 223}, "words": "不作为继续治疗的禁忌症"}, {"probability": {"variance": 0.012447, "average": 0.971093, "min": 0.439197}, "location": {"width": 1240, "top": 982, "height": 50, "left": 223}, "words": "与其他ACE抑制剂相同,有血压过分下降危险的病人,有时伴功能不全,包括充血性心力衰竭"}, {"probability": {"variance": 0.000921, "average": 0.990147, "min": 0.837828}, "location": {"width": 1249, "top": 1027, "height": 45, "left": 226}, "words": "肾血管性高血压、肾透析以及任何病因引起的水分和(或)盐耗竭的病人,对于存在以上任何一"}, {"probability": {"variance": 0.00715, "average": 0.979271, "min": 0.45434}, "location": {"width": 1253, "top": 1071, "height": 45, "left": 221}, "words": "种危险因素的病人,在给予本品治疗前必须谨慎地停止或减少刘尿药的剂量,或者采取其他措施"}, {"probability": {"variance": 0.004668, "average": 0.983413, "min": 0.561921}, "location": {"width": 1251, "top": 1116, "height": 45, "left": 223}, "words": "以保证有充足的体液,这些高危病人的治疗,开始时应该在严密的医疗监护下进行,进行密切的"}, {"probability": {"variance": 0.000947, "average": 0.986367, "min": 0.872575}, "location": {"width": 776, "top": 1160, "height": 47, "left": 223}, "words": "随访,特别在恢复使用和增加利尿药或本品的剂量更应如此"}, {"probability": {"variance": 0.006286, "average": 0.971061, "min": 0.597733}, "location": {"width": 1279, "top": 1203, "height": 47, "left": 196}, "words": "2.肾功能损伤:已患充血性心力衰竭、肾血管性高血压(特别是肾动脉狭窄)和任何原因引起的水或"}, {"probability": {"variance": 0.006765, "average": 0.977441, "min": 0.533416}, "location": {"width": 1251, "top": 1247, "height": 47, "left": 223}, "words": "盐耗竭的病人用ACE抑制剂治疗时,有增加发生肾功能障碍指征的危险,包括血尿素氮升高、血"}, {"probability": {"variance": 0.013138, "average": 0.952377, "min": 0.420779}, "location": {"width": 1251, "top": 1290, "height": 47, "left": 226}, "words": "清肌酐和升高,蛋白尿、尿容量改变(包括尿过少/无尿)和尿分析结果异常。此时,利尿药和"}, {"probability": {"variance": 0.001738, "average": 0.978308, "min": 0.844588}, "location": {"width": 470, "top": 1340, "height": 36, "left": 235}, "words": "(或)本品的剂量应减少或停止使用"}, {"probability": {"variance": 0.013435, "average": 0.964255, "min": 0.385987}, "location": {"width": 1281, "top": 1379, "height": 47, "left": 198}, "words": "3.类过敏症样反应:近来临床观察显示接受ACE抑制剂治疗的病人在用高流量透析膜(AN69)进"}, {"probability": {"variance": 0.012027, "average": 0.960541, "min": 0.511855}, "location": {"width": 1244, "top": 1420, "height": 50, "left": 230}, "words": "行血液透析时有较高的类过敏反应发生率。因此,应该遮免这类联合治疗,在用硫酸聚糖吸收分"}, {"probability": {"variance": 0.009851, "average": 0.963242, "min": 0.475973}, "location": {"width": 1247, "top": 1466, "height": 45, "left": 228}, "words": "离LDL时,也观察到类似的反应,据记录在脱敏治疗中(膜翅目毒素),与其它ACE抑制剂一样也"}, {"probability": {"variance": 0.000447, "average": 0.991645, "min": 0.919551}, "location": {"width": 388, "top": 1514, "height": 43, "left": 226}, "words": "有少数类过敏症样反应的例子"}, {"probability": {"variance": 0.009264, "average": 0.963225, "min": 0.459314}, "location": {"width": 1217, "top": 1553, "height": 45, "left": 239}, "words": "特异反应:已观察到用ACE抑制剂治疗的病人会出现血管性水肿,包括肢体、脸,唇、粘膜、舌"}, {"probability": {"variance": 0.005177, "average": 0.981971, "min": 0.652776}, "location": {"width": 650, "top": 1598, "height": 45, "left": 230}, "words": "声门或喉,如治疗中出现这样的症状,应停止治疗"}, {"probability": {"variance": 0.011407, "average": 0.951807, "min": 0.530574}, "location": {"width": 1272, "top": 1639, "height": 47, "left": 201}, "words": "5.肝功能:据报道用ACE抑刺剂治疗时,有极少数潜在的胆汁性黄痘和肝细胞损害的致死病例。出"}, {"probability": {"variance": 0.000266, "average": 0.992542, "min": 0.923084}, "location": {"width": 744, "top": 1685, "height": 45, "left": 239}, "words": "现黄疸或肝酶明显升高的病人应该停止用ACE抑制剂治疗"}, {"probability": {"variance": 0.009687, "average": 0.951693, "min": 0.432167}, "location": {"width": 1235, "top": 1724, "height": 52, "left": 242}, "words": "高钾症;当用ACE抑制剂治疗时,对肾功能不全,糖尿病病人和合并应用保钾利尿药,补钟剂"}, {"probability": {"variance": 0.005089, "average": 0.968104, "min": 0.735005}, "location": {"width": 712, "top": 1772, "height": 47, "left": 244}, "words": "和(或)含钾盐制刑的病人均有发展为高钾血症的危险"}, {"probability": {"variance": 0.004384, "average": 0.975581, "min": 0.629609}, "location": {"width": 1276, "top": 1815, "height": 47, "left": 198}, "words": "7.中性粒细胞减少症:偶有报道ACE抑制剂可引起粒细胞减少和骨髓抑制;常见于肾功能不全的病"}, {"probability": {"variance": 0.002146, "average": 0.981197, "min": 0.775634}, "location": {"width": 1217, "top": 1859, "height": 47, "left": 242}, "words": "人,特别当病人患有胶原性血管疾病如系统性红斑狼疮或硬皮病,对这类病人应该监测白细胞数"}, {"probability": {"variance": 0.01859, "average": 0.946235, "min": 0.417903}, "location": {"width": 1274, "top": 1902, "height": 47, "left": 198}, "words": "8.手术/麻醉:ACE神制剂可能增强麻醉药和镇痛药的降血压作用进行手术/麻醉同时接受ACE抑"}, {"probability": {"variance": 0.000876, "average": 0.988443, "min": 0.848991}, "location": {"width": 801, "top": 1950, "height": 41, "left": 228}, "words": "制剂治疗的病人如发生低血压:一般可以用静脉补液予以纠正"}, {"probability": {"variance": 0.002824, "average": 0.98722, "min": 0.669507}, "location": {"width": 1155, "top": 1991, "height": 45, "left": 196}, "words": "9.治疗前肾功能的检测:对高血压病人的评价应包括开始治疗前及治疗中对肾功能的检测"}, {"probability": {"variance": 0.000892, "average": 0.988261, "min": 0.886632}, "location": {"width": 406, "top": 2064, "height": 38, "left": 91}, "words": "【孕妇及哺乳期妇女用药】禁用"}, {"probability": {"variance": 0.001622, "average": 0.981755, "min": 0.798992}, "location": {"width": 1000, "top": 2144, "height": 50, "left": 89}, "words": "【儿童用药】现夫进行该项实验且无可靠参考文献,故暂不推荐用于儿童卷者"}], "language": 3}